A year in the life of German patients with COPD: the DACCORD observational study

References

• Global Initiative for Chronic Obstructive Lung Disease [homepage on the Internet]Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease2016 Available from: www.goldcopd.orgAccessed May 6, 2016
   Google Scholar
• CalverleyPMAAndersonJACelliBSalmeterol and fluticasone propionate and survival in chronic obstructive pulmonary diseaseN Engl J Med2007356877578917314337
   PubMed Web of Science ®Google Scholar
• TashkinDPCelliBSennSA 4-year trial of tiotropium in chronic obstructive pulmonary diseaseN Engl J Med2008359151543155418836213
   PubMed Web of Science ®Google Scholar
• VogelmeierCHedererBGlaabTTiotropium versus salmeterol for the prevention of exacerbations of COPDN Engl J Med2011364121093110321428765
   PubMed Web of Science ®Google Scholar
• VestboJAndersonJABrookRDFluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): a double-blind randomised controlled trialLancet2016387100301817182627203508
   PubMed Web of Science ®Google Scholar
• PunekarYSWurstKShuklaAResource use and costs up to two years post diagnosis among newly diagnosed COPD patients in the UK primary care setting: a retrospective cohort studyCOPD201512326727525093809
   PubMedGoogle Scholar
• JamesGDDonaldsonGCWedzichaJANazarethITrends in management and outcomes of COPD patients in primary care, 2000–2009: a retrospective cohort studyNPJ Prim Care Respir Med2014241401524990313
   PubMed Web of Science ®Google Scholar
• StällbergBJansonCJohanssonGManagement, morbidity and mortality of COPD during an 11-year period: an observational retrospective epidemiological register study in Sweden (PATHOS)Prim Care Respir J2014231384524346825
   PubMedGoogle Scholar
• KardosPVogelmeierCBuhlRCriéeC-PWorthHThe prospective non-interventional DACCORD Study in the National COPD Registry in Germany: design and methodsBMC Pulm Med2015151225578330
   PubMed Web of Science ®Google Scholar
• MackayAJDonaldsonGCPatelARCJonesPWHurstJRWedzichaJAUsefulness of the chronic obstructive pulmonary disease assessment test to evaluate severity of COPD exacerbationsAm J Respir Crit Care Med2012185111218122422281834
   PubMed Web of Science ®Google Scholar
• PittaFTroostersTProbstVSSpruitMADecramerMGosselinkRPhysical activity and hospitalization for exacerbation of COPDChest2006129353654416537849
   PubMed Web of Science ®Google Scholar
• SolemCTSunSXSudharshanLMacahiligCKatyalMGaoXExacerbation-related impairment of quality of life and work productivity in severe and very severe chronic obstructive pulmonary diseaseInt J Chron Obstruct Pulmon Dis2013864165224376348
   PubMed Web of Science ®Google Scholar
• BlasiFCesanaGContiSThe clinical and economic impact of exacerbations of chronic obstructive pulmonary disease: a cohort of hospitalized patientsPLoS One201496e10122824971791
   PubMed Web of Science ®Google Scholar
• YuAPYangHWuEQSetyawanJMocarskiMBlumSIncremental third-party costs associated with COPD exacerbations: a retrospective claims analysisJ Med Econ201114331532321500975
   PubMedGoogle Scholar
• PunekarYSShuklaAMüllerovaHCOPD management costs according to the frequency of COPD exacerbations in UK primary careInt J Chron Obstruct Pulmon Dis20149657324426781
   PubMed Web of Science ®Google Scholar
• SuissaSDell’AnielloSErnstPLong-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortalityThorax2012671195796322684094
   PubMed Web of Science ®Google Scholar
• UzaslanEMahboubBBejiMThe burden of chronic obstructive pulmonary disease in the Middle East and North Africa: results of the BREATHE studyRespir Med2012106supplS45S5923290704
   PubMed Web of Science ®Google Scholar
• AnderssonFBorgSJanssonSAThe costs of exacerbations in chronic obstructive pulmonary disease (COPD)Respir Med200296970070812243316
   PubMed Web of Science ®Google Scholar
• Soler-CataluñaJJMartínez-GarcíaMARomán SánchezPSalcedoENavarroMOchandoRSevere acute exacerbations and mortality in patients with chronic obstructive pulmonary diseaseThorax2005601192593116055622
   PubMed Web of Science ®Google Scholar
• HurstJRVestboJAnzuetoASusceptibility to exacerbation in chronic obstructive pulmonary diseaseN Engl J Med2010363121128113820843247
   PubMed Web of Science ®Google Scholar
• CalverleyPPauwelsRVestboJCombined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trialLancet2003361935644945612583942
   PubMed Web of Science ®Google Scholar
• DecramerMLChapmanKRDahlROnce-daily indacaterol versus tiotropium for patients with severe chronic obstructive pulmonary disease (INVIGORATE): a randomised, blinded, parallel-group studyLancet Respir Med20131752453324461613
   PubMed Web of Science ®Google Scholar
• CatesCInhaled corticosteroids in COPD: quantifying risks and benefitsThorax201368649950023242950
   PubMed Web of Science ®Google Scholar
• AgustiAEdwardsLDCelliBCharacteristics, stability and outcomes of the 2011 GOLD COPD groups in the ECLIPSE cohortEur Respir J201342363664623766334
   PubMed Web of Science ®Google Scholar
• HanMKMuellerovaHCurran-EverettDGOLD 2011 disease severity classification in COPDGene: a prospective cohort studyLancet Respir Med201311435024321803
   PubMed Web of Science ®Google Scholar
• LangePMarottJLVestboJPrediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classifi-cation: a study of the general populationAm J Respir Crit Care Med20121861097598122997207
   PubMed Web of Science ®Google Scholar
• HaughneyJGruffydd-JonesKRobertsJLeeAJHardwellAMcGarveyLThe distribution of COPD in UK general practice using the new GOLD classificationEur Respir J2014434993100224176990
   PubMed Web of Science ®Google Scholar
• JonesPWHardingGBerryPWiklundIChenW-HKline LeidyNDevelopment and first validation of the COPD assessment testEur Respir J200934364865419720809
   PubMed Web of Science ®Google Scholar
• WurstKEPunekarYSShuklaATreatment evolution after COPD diagnosis in the UK primary care settingPLoS One201499e10529625180802
   PubMed Web of Science ®Google Scholar
• Penning-van BeestFvan Herk-SukelMGaleRLammersJ-WHeringsRThree-year dispensing patterns with long-acting inhaled drugs in COPD: a database analysisRespir Med2011105225926520705441
   PubMed Web of Science ®Google Scholar